Gastric bypass surgery with exercise alters plasma microRNAs that predict improvements in cardiometabolic risk
- PMID: 28344345
- PMCID: PMC5576445
- DOI: 10.1038/ijo.2017.84
Gastric bypass surgery with exercise alters plasma microRNAs that predict improvements in cardiometabolic risk
Abstract
Background/objectives: Roux-en-Y gastric bypass (RYGB) surgery improves insulin sensitivity (SI) and β-cell function in obese non-diabetic subjects. Exercise also improves SI and may be an effective adjunct therapy to RYGB surgery. However, the mechanisms by which exercise or weight loss improve peripheral SI after RYGB surgery are unclear. We hypothesized that microRNAs (miRNAs) mediate at least some of the regulatory processes driving such mechanisms. Consequently, this work aimed at profiling plasma miRNAs in participants of the Physical Activity Following Surgery Induced Weight Loss study (clinicaltrials.gov identifier: NCT00692367), to assess whether miRNA levels track with improvements in SI and cardiometabolic risk factors.
Subjects/methods: Ninety-four miRNAs implicated in metabolism were profiled in plasma samples from 22 severely obese subjects who were recruited 1-3 months after RYGB surgery and followed for 6 months of RYGB surgery-induced weight loss, with (exercise program (EX), N=11) or without (CON, N=11) an exercise training intervention. The subjects were selected, considering a priori sample size calculations, among the participants in the parent study. Mixed-effect modeling for repeated measures and partial correlation analysis was implemented in the R environment for statistical analysis.
Results: Mirroring results in the parent trial, both groups experienced significant weight loss and improvements in cardiometabolic risk. In the CON group, weight loss significantly altered the pattern of circulating miR-7, miR-15a, miR-34a, miR-106a, miR-122 and miR-221. In the EX group, a distinct miRNA signature was altered: miR-15a, miR-34a, miR-122, miR-135b, miR-144, miR-149 and miR-206. Several miRNAs were significantly associated with improvements in acute insulin response, SI, and other cardiometabolic risk factors.
Conclusions: These findings present novel insights into the RYGB surgery-induced molecular changes and the effects of mild exercise to facilitate and/or maintain the benefits of a 'comprehensive' weight-loss intervention with concomitant improvements in cardiometabolic functions. Notably, we show a predictive value for miR-7, miR-15a, miR-106b and miR-135b.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Dose response of exercise training following roux-en-Y gastric bypass surgery: A randomized trial.Obesity (Silver Spring). 2015 Dec;23(12):2454-61. doi: 10.1002/oby.21332. Epub 2015 Nov 5. Obesity (Silver Spring). 2015. PMID: 26537198 Free PMC article. Clinical Trial.
-
Clinical trial demonstrates exercise following bariatric surgery improves insulin sensitivity.J Clin Invest. 2015 Jan;125(1):248-57. doi: 10.1172/JCI78016. Epub 2014 Dec 1. J Clin Invest. 2015. PMID: 25437877 Free PMC article. Clinical Trial.
-
Role of microRNAs in the treatment of type 2 diabetes mellitus with Roux-en-Y gastric bypass.Braz J Med Biol Res. 2017 Mar 2;50(3):e5817. doi: 10.1590/1414-431X20175817. Braz J Med Biol Res. 2017. PMID: 28273212 Free PMC article.
-
Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.Dan Med J. 2015 Apr;62(4):B5057. Dan Med J. 2015. PMID: 25872541 Review.
-
Circulating miRNAs as Biomarkers of Obesity and Obesity-Associated Comorbidities in Children and Adolescents: A Systematic Review.Nutrients. 2019 Nov 27;11(12):2890. doi: 10.3390/nu11122890. Nutrients. 2019. PMID: 31783635 Free PMC article.
Cited by
-
LncRNAs: Proverbial Genomic "Junk" or Key Epigenetic Regulators During Cardiac Fibrosis in Diabetes?Front Cardiovasc Med. 2018 Apr 4;5:28. doi: 10.3389/fcvm.2018.00028. eCollection 2018. Front Cardiovasc Med. 2018. PMID: 29670886 Free PMC article.
-
A unique plasma microRNA profile defines type 2 diabetes progression.PLoS One. 2017 Dec 4;12(12):e0188980. doi: 10.1371/journal.pone.0188980. eCollection 2017. PLoS One. 2017. PMID: 29200427 Free PMC article.
-
Mechanisms and Outcomes of Metabolic Surgery in Type 2 Diabetes.Metabolites. 2022 Nov 17;12(11):1134. doi: 10.3390/metabo12111134. Metabolites. 2022. PMID: 36422274 Free PMC article. Review.
-
MicroRNAs: The Link between the Metabolic Syndrome and Oncogenesis.Int J Mol Sci. 2021 Jun 13;22(12):6337. doi: 10.3390/ijms22126337. Int J Mol Sci. 2021. PMID: 34199293 Free PMC article. Review.
-
Circulating Liquid Biopsy Biomarkers in Glioblastoma: Advances and Challenges.Int J Mol Sci. 2024 Jul 21;25(14):7974. doi: 10.3390/ijms25147974. Int J Mol Sci. 2024. PMID: 39063215 Free PMC article. Review.
References
-
- Seyhan AA. microRNAs with different functions and roles in disease development and as potential biomarkers of diabetes: progress and challenges. Mol Biosyst. 2015;11:1217–1234. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials